Improving Ischemic Outcomes in ACS: Lessons and Case Discussions from the Experts is organized by C3-Interventional Academy.

Release Date: Nov 01, 2019
Expiration Date: Dec 31, 2019

Target Audience:
This activity is designed for attendees of C3 Annual Meeting and other clinicians: interventional cardiologists, cardiologists, vascular surgeons, cardiothoracic surgeons, primary care physicians, technologists and nurses who mange thrombotic risks across diverse patient populations.

Ciné-Med designates this enduring material for a maximum of 2 AMA PRA Category 1Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity

Educational Objectives:
Upon completion of this activity learners should be able to:
• Discuss the latest guidelines for antiplatelet therapy in ACS
• Describe the impact of oral antiplatelet therapy on Cardiovascular Mortality in ACS
• Outline the latest efficacy and safety data of antiplatelet therapies for patients undergoing PCI
• Explore the advantages and challenges of maintaining longer term antiplatelet therapy for reduction of cardiovascular risk

Additional details will be posted as soon as information is available.


CardiologyVascular Surgery


Diabetes Type 1: Current Approaches in Patient Management for Individuals Diagnosed with Type 1 Diabetes
Oct 06, 2022 - Jun 02, 2025 | Text-Based CME
Endocrinology, Metabolism and Diabetes
2.5 Contact Hours
More actions
Chronic Obstructive Pulmonary Disease (COPD): Patient Management
Feb 12, 2020 - May 01, 2025 | Text-Based CME
6 Contact Hours
More actions
Risk Stratification of a Pulmonary Embolism: What You Need to Know and Why
May 21, 2021 - May 21, 2024 | Text-Based CME
1.5 Contact Hours
More actions